Palomino Laboratories (PALX) Stock Price, News & Analysis
Company Description
For FY2025, Palomino Laboratories reported net income of -$3.2M and diluted earnings per share of $-0.47.
This page collects what Stock Titan holds for PALX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Palomino Laboratories (PALX) last closed at $12.75.
PALX Rankings
Latest News
Palomino Laboratories has 5 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, AI. View all PALX news →
SEC Filings
Palomino Laboratories has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 4, 1 Form 10-Q. The most recent filing was submitted on July 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PALX SEC filings →
Financial Highlights
operating income reached -$2.7M, and net income was -$3.2M. Diluted earnings per share stood at $-0.47. The company generated -$1.3M in operating cash flow. With a current ratio of 25.07, the balance sheet reflects a strong liquidity position.
Upcoming Events
Strategic AI Development Contract
Palomino Laboratories has 1 upcoming scheduled event. The next event, "Strategic AI Development Contract", is scheduled for October 1, 2026 (in 62 days). Investors can track these dates to stay informed about potential catalysts that may affect the PALX stock price.